Fractalkine (FK, CX3CL1) is a novel multidomain protein expressed on the su
rface of endothelial cells. As a full-length transmembrane protein, FK bind
s cells expressing CX3CR1, its cognate receptor, with high affinity. Proteo
lytic cleavage of FK releases a soluble form that is a potent chemoattracta
nt for monocytes, T cells, and natural killer cells. Activation of protein
kinase C dramatically increases the rate of this cleavage. Regulation of FK
cleavage is critical for maintaining the balance between the immobilized a
nd soluble forms, but the protease responsible has not been identified. Her
e we report that tumor necrosis factor-alpha -converting enzyme (TACE) is p
rimarily responsible for the inducible cleavage of FK. After transfection i
nto host cells, the proteolytic cleavage of FK was blocked by TACE-specific
inhibitors and was not detected in cells genetically altered to remove TAL
E activity. In contrast, the constitutive cleavage of FK was not mediated b
y TALE and proceeded normally in TALE-null fibroblasts. We conclude that TA
LE is primarily responsible for the inducible cleavage of FK. These studies
identify a potentially important link between local generation of potent c
ytokines and control of the balance between the cell adhesion and chemotact
ic properties of FK.